Learning from the past: portfolio management in pharma R&D
Pharmaceutical R&D is a complex, long and expensive task with a high project attrition rate. Only 5% of drug projects, that reach the stage of first human dose progress through all phases of clinical trials to reach patients.
Read morePortfolio Visualisation: Making it easy, being transparent, making better decisions
A good understanding of the R&D pipeline and portfolio is essential to reduce waste, duplication and poor use of valuable resources, says Joe de Sousa of AstraZeneca
Read more